1 | English French Notes Complete/Exclude
|
---|
2 | ] New order(s) placed.
|
---|
3 | ] New DC order(s) placed.
|
---|
4 | Abnormal labs - [
|
---|
5 | Abnormal lab:
|
---|
6 | Order requires electronic signature.
|
---|
7 | ] Order placed:
|
---|
8 | ] Result available:
|
---|
9 | Procedure uses non-barium contrast media - abnormal biochem result:
|
---|
10 | Recent Cholecystogram:
|
---|
11 | Patient >65. Renal Results:
|
---|
12 | Missing Labs for Angiogram:
|
---|
13 | Patient allergic to contrast medias:
|
---|
14 | Recent Barium study:
|
---|
15 | WBC < 3.0 and/or ANC < 1.5 - pharmacy cannot fill clozapine order. Most recent results -
|
---|
16 | Clozapine orders require a CBC/Diff within past 7 days. Please order CBC/Diff with WBC and ANC immediately. Most recent results -
|
---|
17 | Most recent results -
|
---|
18 | WBC between 3.0 and 3.5 with ANC >= 1.5 - please repeat CBC/Diff including WBC and ANC immediately and twice weekly. Most recent results -
|
---|
19 | Clozapine - most recent results -
|
---|
20 | Aminoglycoside - est. CrCl:
|
---|
21 | Patient may be
|
---|
22 | Est. CrCl:
|
---|
23 | ordered - adjust diet accordingly.
|
---|
24 | Procedure uses non-barium contrast media and patient is taking glucophage.
|
---|
25 | Potential polypharmacy - patient currently receiving
|
---|
26 | Labs resulted - [
|
---|
27 | Glucophage - Creatinine results:
|
---|
28 | Glucophage - no serum creatinine within past
|
---|
29 | ] Lab threshold exceeded - [
|
---|
30 | Patient has no allergy assessment.
|
---|
31 | Duplicate opioid medications:
|
---|
32 | When the transport routine encounters locally
|
---|
33 | altered rule data at a site, do you want to:
|
---|
34 | (O)verwrite, (D)isplay, or (A)sk the site ?
|
---|
35 | Locally altered data will be overwritten without asking.
|
---|
36 | Locally altered data will be displayed only.
|
---|
37 | Sites will be asked before locally altered data is overwritten.
|
---|
38 | Enter Patch ID (ex. OR*3*96):
|
---|
39 | OR*
|
---|
40 | v = Package Version.
|
---|
41 | ppp = Patch Number.
|
---|
42 | (Delete after Install of
|
---|
43 | Scanning for old rule transport routines...
|
---|
44 | No old rule transport routines found...
|
---|
45 | These routines will be deleted and overwritten.
|
---|
46 | Do you want to proceed?
|
---|
47 | Old rule transport routines not deleted (^%ZOSF(
|
---|
48 | Not Deleted...
|
---|
49 | Select an
|
---|
50 | ***** Already selected for transport. *****
|
---|
51 | None Selected for transport
|
---|
52 | Already selected for transport:
|
---|
53 | Press <Enter> to continue...
|
---|
54 | added to list.
|
---|
55 | removed from list.
|
---|
56 | Select a
|
---|
57 | selected for transport.
|
---|
58 | ORDER CHECK
|
---|
59 | OCX MDD
|
---|
60 | unknown lookup error.
|
---|
61 | could not resolve name.
|
---|
62 | End Transport.
|
---|
63 | already existed.
|
---|
64 | record missing...
|
---|
65 | Unresolved subscript.
|
---|
66 | ^DIE filer data error...
|
---|
67 | ...Correct data Filed
|
---|
68 | Rule Transport aborted, version mismatch.
|
---|
69 | Rule Transport Version: |CVER|
|
---|
70 | Order Check Expert System Rule Transporter
|
---|
71 | data filing error
|
---|
72 | Some expert system rules may be incomplete.
|
---|
73 | No data filing errors.
|
---|
74 | Transport Finished...
|
---|
75 | ] ERROR - RECORD NOT FOUND
|
---|
76 | ACD EXTRACT V10.1
|
---|
77 | Available record layouts:
|
---|
78 | 1) VAACCR Record Layout Version 10.1 (VA Registry)
|
---|
79 | 2) NAACCR State Record Layout Version 10.1
|
---|
80 | Select record layout:
|
---|
81 | Select the record layout to use
|
---|
82 | VACCR EXTRACT V10.1
|
---|
83 | STATE EXTRACT V10.1
|
---|
84 | DISPLAY/PRINT on-line instructions
|
---|
85 | STATE REPORTING ACOS INFOA
|
---|
86 | PRIMARY ACOS INFO (850)
|
---|
87 | Select start date:
|
---|
88 | Select end date:
|
---|
89 | Analytic cases only
|
---|
90 | Answer 'YES' if you want only analytic cases (CLASS OF CASE 0-2) extracted.
|
---|
91 | Answer 'NO' if you want all cases (analytic and non-analytic) extracted.
|
---|
92 | |Please activate your PC capture program. The data will be sent|
|
---|
93 | | in 30 seconds or when you press the return key. |
|
---|
94 | No records extracted.
|
---|
95 | ACoS Report Print
|
---|
96 | State Extract Print
|
---|
97 | Report Canceled!
|
---|
98 | Report Queued!
|
---|
99 | These are your current settings:
|
---|
100 | Record layout.......................:
|
---|
101 | Facility Identification Number (FIN):
|
---|
102 | State to be extracted...............:
|
---|
103 | Accession Year......................:
|
---|
104 | Start date..........................:
|
---|
105 | End date............................:
|
---|
106 | Analytic cases only.................:
|
---|
107 | Are these settings correct
|
---|
108 | Accession Year:
|
---|
109 | Facility Identification Number (FIN)
|
---|
110 | The site paramaters record is being edited by another user.
|
---|
111 | Press ENTER to Continue or
|
---|
112 | to Quit:
|
---|
113 | Col#
|
---|
114 | Data item
|
---|
115 | Data Value
|
---|
116 | ONC(
|
---|
117 | ICDO-TOPOGRAPHY is not defined
|
---|
118 | .........: Surgery performed
|
---|
119 | .........: Radiation performed
|
---|
120 | The Accession Year is not 1995.
|
---|
121 | The Diagnostic Confirmation code is not 1.
|
---|
122 | The Class of Case code is not 0, 1 or 2.
|
---|
123 | Date DX and/or First Treatment Date not in 1995.
|
---|
124 | Select table
|
---|
125 | This primary does not satisfy the PCE eligibility criteria:
|
---|
126 | Patient Care Evaluation Study of Cancers of the Urinary Bladder
|
---|
127 | ACCESSION/SEQUENCE NUMBER
|
---|
128 | CLASS OF CASE
|
---|
129 | REFERRED FOR TREATMENT TO
|
---|
130 | ZIP AT DIAGNOSIS
|
---|
131 | SPANISH ORIGIN
|
---|
132 | PRIMARY PAYER AT DIAGNOSIS
|
---|
133 | PATIENT HISTORY OF OTHER CANCER
|
---|
134 | FAMILY HISTORY OF CANCER
|
---|
135 | SMOKING HISTORY
|
---|
136 | DURATION OF SMOKING HISTORY
|
---|
137 | DURATION OF SMOKE-FREE HISTORY
|
---|
138 | TABLE I - GENERAL INFORMATION
|
---|
139 | ACCESSION/SEQUENCE NUMBER.....:
|
---|
140 | CLASS OF CASE.................:
|
---|
141 | 300REFERRED FOR TREATMENT TO.....
|
---|
142 | 9ZIP AT DIAGNOSIS..............
|
---|
143 | DATE OF BIRTH.................:
|
---|
144 | 9SPANISH ORIGIN................
|
---|
145 | 18PRIMARY PAYER AT DIAGNOSIS....
|
---|
146 | 301LENGTH OF STAY................
|
---|
147 | PATIENT HISTORY OF OTHER CANCER:
|
---|
148 | 305 HEAD AND NECK...............
|
---|
149 | FAMILY HISTORY OF CANCER:
|
---|
150 | 314SMOKING HISTORY (PACKS/DAY)...
|
---|
151 | 315DURATION OF SMOKING HISTORY...
|
---|
152 | 316DURATION OF SMOKE-FREE HISTORY
|
---|
153 | GO TO:
|
---|
154 | CLINICAL DETECTION
|
---|
155 | ONSET OF SYMPTOMS
|
---|
156 | DURATION OF SYMPTOMS BEFORE DIAGNOSIS
|
---|
157 | DIAGNOSTIC PROCEDURES
|
---|
158 | DATE OF INITIAL DIAGNOSIS
|
---|
159 | SPECIALTY MAKING DIAGNOSIS
|
---|
160 | PRIMARY SITE (ICD-O-2)
|
---|
161 | HISTOLOGY (ICD-O-2)
|
---|
162 | TABLE II- DIAGNOSTIC INFORMATION
|
---|
163 | CLINICAL DETECTION:
|
---|
164 | 317 GROSS HEMATURIA................
|
---|
165 | 318 MICROSCOPIC HEMATURIA..........
|
---|
166 | 319 URINARY FREQUENCY..............
|
---|
167 | 320 BLADDER IRRITABILITY...........
|
---|
168 | 323ONSET OF SYMPTOMS................
|
---|
169 | DURATION OF SYMPTOMS (months) BEFORE DIAGNOSIS:
|
---|
170 | 324 GROSS HEMATURIA................
|
---|
171 | DIAGNOSTIC PROCEDURES:
|
---|
172 | 326 BIMANUAL EXAMINATION OF BLADDER
|
---|
173 | 327 CYSTOSCOPY WITH BIOPSY.........
|
---|
174 | 328 CYSTOSCOPY WITHOUT BIOPSY......
|
---|
175 | 329 FLOW CYTOMETRY.................
|
---|
176 | 330 INTRAVENOUS PYELOGRAM..........
|
---|
177 | 331 URINE CYTOLOGY.................
|
---|
178 | DATE OF INITIAL DIAGNOSIS........:
|
---|
179 | 334SPECIALTY MAKING DIAGNOSIS.......
|
---|
180 | PRIMARY SITE (ICD-O-2)...........:
|
---|
181 | HISTOLOGY (ICD-O-2)..............:
|
---|
182 | STAGING PROCEDURES
|
---|
183 | PRESENCE OF HYDRONEPHROSIS
|
---|
184 | TUMOR SIZE (mm)
|
---|
185 | PRESENCE OF MULTIPLE TUMORS
|
---|
186 | REGIONAL NODES EXAMINED
|
---|
187 | REGIONAL NODES POSITIVE
|
---|
188 | SITES OF DISTANT METASTASIS
|
---|
189 | AJCC CLINICAL STAGE (cTNM)
|
---|
190 | AJCC PATHOLOGIC STAGE (pTNM)
|
---|
191 | STAGED BY
|
---|
192 | TABLE III- EXTENT OF DISEASE AND AJCC STAGE
|
---|
193 | STAGING PROCEDURES:
|
---|
194 | 335 ABDOMINAL ULTRASOUND.........
|
---|
195 | 336 BONE IMAGING.................
|
---|
196 | 338 CT CHEST/LUNG................
|
---|
197 | 339 CT ABDOMEN/PELVIS............
|
---|
198 | 340 CT OTHER.....................
|
---|
199 | 341 MRI PELVIS/ABDOMEN...........
|
---|
200 | 342 MRI OTHER....................
|
---|
201 | 344PRESENCE OF HYDRONEPHROSIS.....
|
---|
202 | 29TUMOR SIZE (mm)................
|
---|
203 | 345PRESENCE OF MULTIPLE TUMORS....
|
---|
204 | 33REGIONAL NODES EXAMINED........
|
---|
205 | 32REGIONAL NODES POSITIVE........
|
---|
206 | SITES OF DISTANT METASTASIS:
|
---|
207 | 34 SITE OF DISTANT METASTASIS #1
|
---|
208 | SITE OF DISTANT METASTASIS #2: None
|
---|
209 | SITE OF DISTANT METASTASIS #3: None
|
---|
210 | 34.1 SITE OF DISTANT METASTASIS #2
|
---|
211 | 34.2 SITE OF DISTANT METASTASIS #3
|
---|
212 | AJCC CLINICAL STAGE (cTNM):
|
---|
213 | 38AJCC STAGE.....................
|
---|
214 | AJCC PATHOLOGIC STAGE (pTNM):
|
---|
215 | 88AJCC STAGE.....................
|
---|
216 | STAGED BY:
|
---|
217 | 19 CLINICAL STAGE....................
|
---|
218 | 89 PATHOLOGIC STAGE..................
|
---|
219 | DATE OF INITIAL TREATMENT
|
---|
220 | PROTOCOL ELIGIBILITY STATUS
|
---|
221 | MANAGING PHYSICIANS
|
---|
222 | RADIATION THERAPY
|
---|
223 | TABLE IV - FIRST COURSE OF TREATMENT
|
---|
224 | DATE OF INITIAL TREATMENT...........:
|
---|
225 | 346PROTOCOL ELIGIBILITY STATUS.........
|
---|
226 | MANAGING PHYSICIANS:
|
---|
227 | 347 PRIMARY PHYSICIAN.................
|
---|
228 | 348 SECONDARY PHYSICIAN...............
|
---|
229 | SURGERY:
|
---|
230 | DATE OF SURGERY...................:
|
---|
231 | TYPE OF SURGERY...................:
|
---|
232 | TUMOR RESECTION DURING TURB.......: Not applicable
|
---|
233 | 349 TUMOR RESECTION DURING TURB.......
|
---|
234 | TYPE OF URINARY DIVERSION.........: Not applicable
|
---|
235 | 350 TYPE OF URINARY DIVERSION.........
|
---|
236 | PELVIC LYMPH NODE DISSECTION......: Not applicable
|
---|
237 | 351 PELVIC LYMPH NODE DISSECTION......
|
---|
238 | SURGICAL COMPLICATIONS:
|
---|
239 | BLEEDING REQUIRING TRANSFUSION..: No
|
---|
240 | DEEP VENOUS THROMBOSIS..........: No
|
---|
241 | MYOCARDIAL INFARCTION/ARRHYTHMIA: No
|
---|
242 | PELVIC ABSCESS..................: No
|
---|
243 | PNEUMONIA REQUIRING ANTIBIOTICS.: No
|
---|
244 | POST-OPERATIVE DEATH (30 DAYS)..: No
|
---|
245 | PULMONARY EMBOLISM/THROMBOSIS...: No
|
---|
246 | 352 BLEEDING REQUIRING TRANSFUSION..
|
---|
247 | 353 DEEP VENOUS THROMBOSIS..........
|
---|
248 | 354 MYOCARDIAL INFARCTION/ARRHYTHMIA
|
---|
249 | 355 PELVIC ABSCESS..................
|
---|
250 | 356 PNEUMONIA REQUIRING ANTIBIOTICS.
|
---|
251 | 357 POST-OPERATIVE DEATH (30 DAYS)..
|
---|
252 | 358 PULMONARY EMBOLISM/THROMBOSIS...
|
---|
253 | RADIATION THERAPY:
|
---|
254 | RADIATION THERAPY.................:
|
---|
255 | DATE RADIATION THERAPY STARTED....:
|
---|
256 | DATE RADIATION THERAPY ENDED......: 00/00/0000
|
---|
257 | TOTAL RAD (cGy/rad) DOSE..........: 00000
|
---|
258 | REGIONAL TREATMENT MODALITY.......: No radiation therapy
|
---|
259 | RADIATION COMPLICATIONS:
|
---|
260 | URINARY INCONTINENCE............: Not applicable
|
---|
261 | HEMATURIA.......................: Not applicable
|
---|
262 | RADIATION BOWEL INJURY..........: Not applicable
|
---|
263 | DATE RADIATION THERAPY ENDED......: 99/99/9999
|
---|
264 | TOTAL RAD (cGy/rad) DOSE..........: 99999
|
---|
265 | REGIONAL TREATMENT MODALITY.......: Unknown
|
---|
266 | URINARY INCONTINENCE............: Unknown
|
---|
267 | RADIATION BOWEL INJURY..........: Unknown
|
---|
268 | 361 DATE RADIATION THERAPY ENDED......
|
---|
269 | 362 TOTAL RAD (cGy/rad) DOSE..........
|
---|
270 | 363 REGIONAL TREATMENT MODALITY.......
|
---|
271 | 364 URINARY INCONTINENCE............
|
---|
272 | 366 RADIATION BOWEL INJURY..........
|
---|
273 | CHEMOTHERAPY:
|
---|
274 | DATE CHEMOTHERAPY STARTED.........:
|
---|
275 | DATE CHEMOTHERAPY ENDED...........: 00/00/0000
|
---|
276 | ROUTE CHEMOTHERAPY ADMINISTERED...: No chemotherapy
|
---|
277 | TYPES OF AGENTS ADMINISTERED:
|
---|
278 | ADRIAMYCIN......: None IFOSFAMIDE......: None
|
---|
279 | CARBOPLATINUM...: None METHOTREXATE....: None
|
---|
280 | CISPLATIN.......: None TAXOL...........: None
|
---|
281 | CYCLOPHOSPHAMIDE: None THIOTEPA........: None
|
---|
282 | 5-FLUOROURACIL..: None VINBLASTINE.....: None
|
---|
283 | GALLIUM NITRATE.: None OTHER...........: None
|
---|
284 | INDICATION FOR ADMIN OF AGENTS....: No agents administered, NA
|
---|
285 | REASON CHEMOTHERAPY STOPPED.......: Treatment completed, NA
|
---|
286 | DATE CHEMOTHERAPY ENDED...........: 99/99/9999
|
---|
287 | ROUTE CHEMOTHERAPY ADMINISTERED...: Unknown
|
---|
288 | ADRIAMYCIN......: Unknown IFOSFAMIDE......: Unknown
|
---|
289 | CARBOPLATINUM...: Unknown METHOTREXATE....: Unknown
|
---|
290 | CISPLATIN.......: Unknown TAXOL...........: Unknown
|
---|
291 | CYCLOPHOSPHAMIDE: Unknown THIOTEPA........: Unknown
|
---|
292 | 5-FLUOROURACIL..: Unknown VINBLASTINE.....: Unknown
|
---|
293 | GALLIUM NITRATE.: Unknown OTHER...........: Unknown
|
---|
294 | INDICATION FOR ADMIN OF AGENTS....: Unknown
|
---|
295 | REASON CHEMOTHERAPY STOPPED.......: Unknown
|
---|
296 | 367 DATE CHEMOTHERAPY ENDED...........
|
---|
297 | 368 ROUTE CHEMOTHERAPY ADMINISTERED...
|
---|
298 | 374 GALLIUM NITRATE.................
|
---|
299 | 380 OTHER AGENT.....................
|
---|
300 | 381 INDICATION FOR ADMIN OF AGENTS....
|
---|
301 | 382 REASON CHEMOTHERAPY STOPPED.......
|
---|
302 | IMMUNOTHERAPY:
|
---|
303 | #################### #################### ####################
|
---|
304 | #################### #################### ####################
|
---|
305 | #################### #################### ####################
|
---|
306 | #################### #################### ####################
|
---|
307 | #################### #################### ####################
|
---|